Gland Pharma Limited (NSE: GLAND) reports record revenues and profitability with 22% YoY growth in Q4 FY26 and 97% PAT growth.
Indoco Remedies Limited (INDOCO) receives Malta Medicines Authority audit approval for its Baddi facility, confirming compliance with EU GMP standards.
Lupin Limited (LUPIN) announced U.S. FDA approval for Famotidine Injection, expanding its pharmaceutical portfolio with a bioequivalent to Pepcid®.
OneSource Specialty Pharma Limited (NSE: ONESOURCE) announced strong Q4 FY26 results with revenue up 47% QoQ and EBITDA expanding more than 5x.
USFDA inspection concludes at Zydus Lifesciences Limited's Biologics Injectable plant in Ahmedabad with seven observations.
Dishman Carbogen Amcis Limited's subsidiary, CARBOGEN AMCIS Shanghai, successfully passes an unannounced GMP inspection by China’s NMPA.
Wockhardt Limited reports strong FY 26 financials with Rs. 238 Cr profit before tax, marking significant growth in revenue and EBITDA.